10X Genomics (TXG) PT Raised to $47 at Piper Sandler
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $68.99 +3.93%
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
- Bank Central Asia Tbk (BBCA:IJ) (PBCRY) PT Raised to INR7,630 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
